At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
"In-Clinic LVAT"device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of LEft VEntricular Auto Threshold Algorithm
In Brief
A clinical study evaluating "In-Clinic LVAT" for Heart Failure. Completed, enrolled 60 participants across 1 site.
Detailed Summary
The purpose of the LEVEA study is to assess the performances of a new automatic left ventricular auto threshold (LVAT) algorithm (In-Clinic LVAT algorithm) when used by physicians during in-hospital follow-up.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJan 2017
Enrollment StartFeb 2017
Primary CompletionAug 2017
TodayJul 2026
First PostedJan 9, 2017
Enrollment StartFeb 16, 2017
Primary CompletionAug 17, 2017
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 9.5 years ago
Interventions
"In-Clinic LVAT"device
Algorithm offers automatic threshold measurement of differents vectors of left ventricular stimulation.